GENPHARMASEC Financial Statement Analysis
|
||
The Revenues of GENPHARMASEC have increased by 19.16% YoY .
The Earnings Per Share (EPS) of GENPHARMASEC has decreased by -100.00 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
GENPHARMASEC Last 5 Annual Financial Results
[BOM: 531592]
Consolidated | Mar2024 | Mar2023 |
---|---|---|
Revenues | ₹30 Cr | ₹26 Cr |
Expenses | ₹30 Cr | ₹25 Cr |
Operating Profit (Excl OI) | ₹0.05 Cr | ₹0.26 Cr |
Other Income | ₹0.66 Cr | ₹0.10 Cr |
Interest | ₹0.41 Cr | ₹0.06 Cr |
Depreciation | ₹0.04 Cr | ₹0.02 Cr |
Profit Before Tax | ₹0.25 Cr | ₹0.28 Cr |
Profit After Tax | ₹-0.17 Cr | ₹1.13 Cr |
Consolidated Net Profit | ₹-0.13 Cr | ₹1.13 Cr |
Earnings Per Share (Rs) | ₹0.00 | ₹0.04 |
PAT Margin (%) | -0.56 | 4.41 |
ROE(%) | -0.42 | 7.34 |
ROCE(%) | 1.53 | 1.83 |
Total Debt/Equity(x) | 0.05 | 0.20 |
Key Financials |
||
Market Cap | : | ₹ 111.8 Cr |
Revenue (TTM) | : | ₹ 33.7 Cr |
Net Profit(TTM) | : | ₹ 1.5 Cr |
EPS (TTM) | : | ₹ 0.0 |
P/E (TTM) | : | 74.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
GENPHARMASEC | NA | -8.2% | -14.1% |
SUDARSHAN CHEMICAL INDUSTRIES | -1% | -2.5% | 36.5% |
KIRI INDUSTRIES | -0.6% | -6.5% | 55.3% |
VIDHI SPECIALTY FOOD INGREDIENTS | -1.3% | -3% | -2.3% |
SHREE PUSHKAR CHEMICALS & FERTILISERS | 5.6% | 9.6% | 44.2% |
BODAL CHEMICALS | -2% | 1% | -5.4% |
BHAGERIA INDUSTRIES | 0.2% | 10.3% | 17.1% |
DYNEMIC PRODUCTS | 11.2% | 11.7% | -6.8% |
PODDAR PIGMENTS | -3.6% | 0.2% | -30.7% |
GENPHARMASEC Revenues
[BOM: 531592]
Y-o-Y | 19.16 % |
5 Yr CAGR | 19.16 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | 19.16 | |
Mar2023 | ₹26 Cr | - |
GENPHARMASEC Operating Profit
[BOM: 531592]
Y-o-Y | -82.10 % |
5 Yr CAGR | -82.10 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹0.05 Cr | -82.10 | |
Mar2023 | ₹0.26 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -85.15 % |
5 Yr CAGR | -85.15 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 0.15% | -85.15 | |
Mar2023 | 1.01% | - |
GENPHARMASEC Profit After Tax
[BOM: 531592]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹-0.13 Cr | Negative | |
Mar2023 | ₹1.13 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | -0.56 % | Negative | |
Mar2023 | 4.41 % | - |
GENPHARMASEC Earnings Per Share (EPS)
[BOM: 531592]
Y-o-Y | -100.00 % |
5 Yr CAGR | -100.00 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹0.00 | -100.00 | |
Mar2023 | ₹0.04 | - |
GENPHARMASEC Return on Capital Employed (ROCE)
[BOM: 531592]
Y-o-Y | -16.39 % |
5 Yr CAGR | -16.39 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 1.53% | -16.39 | |
Mar2023 | 1.83% | - |
GENPHARMASEC Share Price vs Sensex
Current Share Price | : | ₹2.0 |
Current MarketCap | : | ₹ 111.8 Cr |
Updated EOD on | : | Jul 11,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENPHARMASEC | NA |
-8.2% |
-14.1% |
SENSEX | -1.1% |
-0% |
3.2% |
GENPHARMASEC related INDICES
You may also like the below Video Courses
FAQ about GENPHARMASEC Financials
How the annual revenues of GENPHARMASEC have changed ?
The Revenues of GENPHARMASEC have increased by 19.16% YoY .
How the Earnings per Share (EPS) of GENPHARMASEC have changed?
The Earnings Per Share (EPS) of GENPHARMASEC has decreased by -100.00 % YoY .
SUDARSHAN CHEMICAL INDUSTRIES LTD vs KIRI INDUSTRIES LTD vs VIDHI SPECIALTY FOOD INGREDIENTS LTD
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD vs BODAL CHEMICALS LTD vs